Vaccinex, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Vaccinex, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $15.00K.
- Vaccinex, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-03-31 was $4.00K.
- Vaccinex, Inc. stock issued during period, value, stock options exercised for the quarter ending 2018-12-31 was $0.00.
- Vaccinex, Inc. stock issued during period, value, stock options exercised for the quarter ending 2018-09-30 was $0.00.
- Vaccinex, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $19.00K.
- Vaccinex, Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $5.00K, a 66.67% decline from fiscal 2017.
- Vaccinex, Inc. stock issued during period, value, stock options exercised for fiscal 2017 was $15.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2020-12-31 | $19.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $15.00K 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $4.00K 10-Q · filed 2021-11-08 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $5.00K 10-K · filed 2020-03-09 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | |
| 2018-06-30 | $5.00K 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $15.00K 10-K · filed 2019-03-13 |